Optomed PlcStock Exchange Release18 June 2026 at 17.30, Helsinki
Inside Information: Optomed receives a large order in the US
Optomed has received an order of approximately USD 2.1 million (EUR 1.8 million)
from a US screening service provider and distributor in the US. The order is for
traditional capital sales and does not include AI service or a recurring revenue
component.
The order is expected to have a positive effect on the Devices segment for the
second half of the year.
Outlook unchanged: Optomed expects its full year 2026 revenue to grow compared
to 2025.
Optomed Plc
Further enquiries
Juho Himberg, CEO, Optomed Plc, juho.himberg@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers
of handheld fundus cameras. Optomed combines handheld fundus cameras with
software and artificial intelligence with the aim to transform the diagnostic
process of blinding eye diseases, such as rapidly increasing diabetic
retinopathy. In its business Optomed focuses on eye screening devices and
software solutions related R&D in Finland and sales through different channels
in over 60 countries.
www.optomed.com